Qiming leads New Horizon's $20M series B

Cancer screening company New Horizon Health Technology Co. Ltd. (Hangzhou, China) raised $20 million in a series B round led by Qiming Venture Partners. Legend Capital, SoftBank China and Purdue Technology Investment Inc. also participated.

New Horizon plans to use the financing to expand its pipeline of at-home early screening tests for cancers that are high-risk in China...